Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 28, 2014 - Issue 18
263
Views
10
CrossRef citations to date
0
Altmetric
Articles

Anti-depressive activities and biotransformation of timosaponin B-III and its derivatives

, , , , , & show all
Pages 1446-1453 | Received 28 Nov 2013, Accepted 29 Mar 2014, Published online: 22 Apr 2014
 

Abstract

Timosaponin B-III (TB-III) is a steroidal saponin isolated from the rhizome of Anemarrhenae asphodeloides (Liliaceae). The biotransformation of TB-III by β-glucosidase was investigated. Three biotransformation products were isolated and their structures were identified as timosaponin B-III-a (M1), (20R,25S)-5β-spirostane-3β-ol-3-O-β-d-glucopyranosyl-(1 → 2)-β-d-galacopyanoside (M2) and timosaponin AIII (M3). Then the four compounds were evaluated for their anti-depressive activity in mice by the open field test, tail suspension test and forced swimming test. As a result, TB-III, M1 and M3 exhibited modest anti-depressive activity. Structure–activity relationships were investigated and the preliminary conclusions are summarised as follows: the glycosyl at C-3 and C-26 can increase the activity, the double bond between C-20 and C-22 might be important for the anti-depressive activity, the R-configuration at C-22 and S-configuration at C-20 are necessary for its anti-depressive activity.

Acknowledgements

This project received support from the National Science & Technology Major Project ‘Key New Drug Creation and Manufacturing Program’, China [No. 2012ZX09301001-001].

Notes

1. These authors contributed equally to this work and should be considered co-first authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.